{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:58:55Z","timestamp":1773262735463,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.msard.2020.102730","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T20:41:35Z","timestamp":1609360895000},"page":"102730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Neuro-ophthalmologic manifestations of multiple sclerosis other than acute optic neuritis"],"prefix":"10.1016","volume":"48","author":[{"given":"Joana","family":"Costa Novo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7355-9153","authenticated-orcid":false,"given":"Helena","family":"Felgueiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.msard.2020.102730_bib0001","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jnnp.55.9.747","article-title":"The ocular manifestations of multiple sclerosis 1 Abnormalities of the afferent visual system","volume":"55","author":"McDonald","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1474-4422(05)00992-0","article-title":"The neuro-ophthalmology of multiple sclerosis","volume":"4","author":"Frohman","year":"2005","journal-title":"Lancet. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2020.102730_bib0003","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.msard.2020.102730_bib0004","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2000-6836","article-title":"Optic neuropathies for the neurologist","volume":"20","author":"Purvin","year":"2000","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.msard.2020.102730_bib0005","doi-asserted-by":"crossref","unstructured":"S. J. Hickman, N. Raoof, R. J. McLean, and I. Gottlob, \u201cVision and multiple sclerosis,\u201d vol. 3, no. 1, pp. 3\u201316, 2014.","DOI":"10.1016\/j.msard.2013.04.004"},{"key":"10.1016\/j.msard.2020.102730_bib0006","series-title":"Symptomatic retrochiasmal lesions in multiple sclerosis: Clinical features, visual evoked potentials, and magnetic resonance imaging","author":"Plant","year":"1992"},{"issue":"1","key":"10.1016\/j.msard.2020.102730_bib0007","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.42.1.77","article-title":"Frequent involvement of the optic radiation in patients with acute isolated optic neuritis","volume":"42","author":"Hornabrook","year":"1992","journal-title":"Neurology"},{"issue":"SUPPL. 1","key":"10.1016\/j.msard.2020.102730_bib0008","first-page":"42","article-title":"Optic nerve imaging in multiple sclerosis","volume":"17","author":"Hickman","year":"2007","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.msard.2020.102730_bib0009","series-title":"Ocular motor disorders associated with cerebellar lesions: Pathophysiology and topical localization","author":"Lewis","year":"1993"},{"key":"10.1016\/j.msard.2020.102730_bib0010","series-title":"Internuclear ophthalmoplegia: pathophysiology and diagnosis.","author":"Zee","year":"1992"},{"issue":"3","key":"10.1016\/j.msard.2020.102730_bib0011","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/WNO.0000000000000507","article-title":"Ocular Motor Manifestations of Multiple Sclerosis","volume":"37","author":"Nerrant","year":"2017","journal-title":"J. Neuroophthalmol."},{"issue":"3","key":"10.1016\/j.msard.2020.102730_bib0012","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ncl.2010.03.006","article-title":"Eye movement abnormalities in multiple sclerosis","volume":"28","author":"Prasad","year":"2010","journal-title":"Neurol. Clin."},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0036-1579692","article-title":"Vision Disturbances in Multiple Sclerosis","volume":"36","author":"Costello","year":"2016","journal-title":"Semin. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2020.102730_bib0014","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.57.5.762","article-title":"MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis","volume":"57","author":"Frohman","year":"2001","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2020.102730_bib0015","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1212\/01.WNL.0000123093.37069.6D","article-title":"Internuclear ophthalmoplegia as an isolated or predominant symptom of brainstem infarction","volume":"62","author":"Kim","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0016","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/practneurol-2016-001428","article-title":"Internuclear ophthalmoplegia","volume":"17","author":"Virgo","year":"2017","journal-title":"Pract. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2020.102730_bib0017","first-page":"1","article-title":"Anatomic review and topographic diagnosis","volume":"14","author":"Balcer","year":"2001","journal-title":"Ophthalmol. Clin. North Am."},{"key":"10.1016\/j.msard.2020.102730_bib0018","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0074-7742(07)79028-1","article-title":"Optic neuritis and the neuro-ophthalmology of multiple sclerosis","volume":"79","author":"Kaur","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"issue":"5","key":"10.1016\/j.msard.2020.102730_bib0019","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1212\/CON.0000000000000772","article-title":"Nystagmus and Saccadic Intrusions","volume":"25","author":"Rucker","year":"2019","journal-title":"Continuum (Minneap. Minn)."},{"key":"10.1016\/j.msard.2020.102730_bib0020","article-title":"Uveitis associated with multiple sclerosis","author":"Scanff","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2020.102730_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/372361","article-title":"Ipsilateral Uveitis and Optic Neuritis in Multiple Sclerosis","volume":"2012","author":"Thouvenot","year":"2012","journal-title":"Mult. Scler. Int."},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0022","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/bjophthalmol-2014-305518","article-title":"Characterisation of uveitis in association with multiple sclerosis","volume":"99","author":"Messenger","year":"2015","journal-title":"Br. J. Ophthalmol."},{"issue":"Pt 2","key":"10.1016\/j.msard.2020.102730_bib0023","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/brain\/110.2.405","article-title":"Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis","volume":"110","author":"Lightman","year":"1987","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.msard.2020.102730_bib0024","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1212\/WNL.0b013e3182a3525e","article-title":"Retinal periphlebitis is associated with multiple sclerosis severity","volume":"81","author":"Ortiz-Perez","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000116912","article-title":"Retinal periphlebitis in multiple sclerosis: a marker of disease activity?","volume":"33","author":"Tola","year":"1993","journal-title":"Eur. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0026","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1442-9071.2000.00270.x","article-title":"Symptomatic intraocular inflammation in multiple sclerosis","volume":"28","author":"Towler","year":"2000","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.msard.2020.102730_bib0027","doi-asserted-by":"crossref","unstructured":"G. Zein, A. Berta, and C. S. Foster, \u201cOriginal article Multiple sclerosis-associated uveitis,\u201d pp. 137\u2013142, 2004.","DOI":"10.1080\/09273940490895344"},{"issue":"3","key":"10.1016\/j.msard.2020.102730_bib0028","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/08820530500232035","article-title":"Intermediate uveitis","volume":"20","author":"Bonfioli","year":"2005","journal-title":"Semin. Ophthalmol."},{"issue":"4","key":"10.1016\/j.msard.2020.102730_bib0029","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4103\/2008-322X.176897","article-title":"Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis","volume":"10","author":"Ozdal","year":"2015","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.msard.2020.102730_bib0030","article-title":"Inflammation in the region of the vitreous base. Pars planitis","author":"Chester","year":"1976","journal-title":"Trans. Ophthalmol. Soc. U. K."},{"key":"10.1016\/j.msard.2020.102730_bib0031","doi-asserted-by":"crossref","DOI":"10.4103\/0301-4738.58468","article-title":"Current approach in diagnosis and management of anterior uveitis","author":"Agrawal","year":"2010","journal-title":"Indian Journal of Ophthalmology"},{"issue":"4","key":"10.1016\/j.msard.2020.102730_bib0032","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.msard.2020.102730_bib0033","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography","volume":"59","author":"Costello","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2020.102730_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/S0967-5868(96)90063-6","article-title":"Progressive visual loss: An unusual presentation of multiple sclerosis","author":"Read","year":"1996","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.msard.2020.102730_bib0035","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.23.7.729","article-title":"Slowly progressive and acute visual impairment in multiple sclerosis","author":"Kahana","year":"1973","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102730_bib0036","doi-asserted-by":"crossref","DOI":"10.1177\/1352458513479840","article-title":"Persistent visual impairment in multiple sclerosis: Prevalence, mechanisms and resulting disability","author":"Jasse","year":"2013","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2020.102730_bib0037","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2013.98","article-title":"Uhthoff's phenomena in MS - Clinical features and pathophysiology","author":"Frohman","year":"2013","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.msard.2020.102730_bib0038","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.2006.094771","article-title":"An unusual presentation of optic neuritis and the Pulfrich phenomenon [2]","author":"O'Doherty","year":"2007","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-510X(01)00461-0","article-title":"Visual object recognition in multiple sclerosis","volume":"185","author":"Laatu","year":"2001","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.msard.2020.102730_bib0040","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/1352458515607650","article-title":"Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study","volume":"22","author":"Tillema","year":"2016","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.msard.2020.102730_bib0041","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/jnnp.2010.239715","article-title":"Early pericalcarine atrophy in acute optic neuritis is associated with conversion to multiple sclerosis","volume":"82","author":"Jenkins","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0042","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archneurol.2008.562","article-title":"Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway","volume":"66","author":"Sepulcre","year":"2009","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2020.102730_bib0043","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1212\/WNL.38.8.1335-a","article-title":"Inverted vision in MS","volume":"38","author":"Seigel","year":"1988","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2020.102730_bib0044","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000117139","article-title":"Peduncular hallucinosis as the first manifestation of multiple sclerosis","volume":"35","author":"Nicolai","year":"1995","journal-title":"European neurology"},{"issue":"4","key":"10.1016\/j.msard.2020.102730_bib0045","first-page":"251","article-title":"Palinopsia and bitemporal visual extinction on fixation","volume":"17","author":"Jacome","year":"1985","journal-title":"Ann. Ophthalmol."},{"key":"10.1016\/j.msard.2020.102730_bib0046","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","author":"Kappos","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2020.102730_bib0047","unstructured":"V. Brinkmann, M. HW, J. N, and B. Metzler, The mode of action of FTY720 (Fingolimod), an oral sphingosine 1-phosphate receptor modulator that is highly effective in human multiple sclerosis (Phase II). 2008."},{"key":"10.1016\/j.msard.2020.102730_bib0048","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e31827b9132","article-title":"Fingolimod treatment in multiple sclerosis leads to increased macular volume","author":"Nolan","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0049","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/eye.2016.258","article-title":"Fingolimod: therapeutic mechanisms and ocular adverse effects","volume":"31","author":"Mandal","year":"2017","journal-title":"Eye (Lond)"},{"issue":"12","key":"10.1016\/j.msard.2020.102730_bib0050","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1111\/j.1600-6143.2006.01552.x","article-title":"FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and Australasia","volume":"6","author":"Salvadori","year":"2006","journal-title":"Am. J. Transplant"},{"issue":"12","key":"10.1016\/j.msard.2020.102730_bib0051","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/01.tp.0000251718.95622.b3","article-title":"Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation","volume":"82","author":"Tedesco-Silva","year":"2006","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.msard.2020.102730_bib0052","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ophtha.2012.12.040","article-title":"Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis","volume":"120","author":"Zarbin","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2020.102730_bib0053","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0b013e318248deea","article-title":"Fingolimod-associated macular edema: Incidence, detection, and management","author":"Jain","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102730_bib0054","doi-asserted-by":"crossref","DOI":"10.1097\/WNO.0b013e31829b42e1","article-title":"Fingolimod therapy and macular hemorrhage","author":"Bhatti","year":"2013","journal-title":"Journal of Neuro-Ophthalmology"},{"issue":"3","key":"10.1016\/j.msard.2020.102730_bib0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/WNO.0b013e31822bed20","article-title":"Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis","volume":"31","author":"Gallego-Pinazo","year":"2011","journal-title":"Journal of neuro-ophthalmology\u00a0: the official journal of the North American Neuro-Ophthalmology Society"},{"key":"10.1016\/j.msard.2020.102730_bib0056","doi-asserted-by":"crossref","DOI":"10.2147\/tcrm.2007.3.2.259","article-title":"Natalizumab: A new treatment for relapsing remitting multiple sclerosis","author":"Hutchinson","year":"2007","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"10.1016\/j.msard.2020.102730_bib0057","series-title":"Natalizumab: A review of its use in the management of relapsing-remitting multiple sclerosis","author":"McCormack","year":"2013"},{"key":"10.1016\/j.msard.2020.102730_bib0058","article-title":"Neuro-ophthalmic findings in progressive multifocal leukoencephalopathy","author":"Wein","year":"1998","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.msard.2020.102730_bib0059","first-page":"109","article-title":"Progressive Multifocal Leukoencephalopathy: Current Insights","volume":"9","author":"Kartau","year":"2019","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"issue":"8","key":"10.1016\/j.msard.2020.102730_bib0060","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/1352458518786075","article-title":"Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients","volume":"25","author":"Oshima","year":"2019","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2020.102730_bib0061","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ene.13906","article-title":"The spectrum of progressive multifocal leukoencephalopathy: a practical approach","volume":"26","author":"Bartsch","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2020.102730_bib0062","doi-asserted-by":"crossref","DOI":"10.1002\/ana.23973","article-title":"JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment","author":"Schippling","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2020.102730_bib0063","article-title":"Alemtuzumab for multiple sclerosis","volume":"4","author":"Riera","year":"2016","journal-title":"Cochrane database Syst. Rev."},{"issue":"6","key":"10.1016\/j.msard.2020.102730_bib0064","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/IOP.0000000000000310","article-title":"Ocular Findings in Alemtuzumab (Campath-1H)-induced Thyroid Eye Disease","volume":"32","author":"Trinh","year":"2016","journal-title":"Ophthal. Plast. Reconstr. Surg."},{"issue":"1","key":"10.1016\/j.msard.2020.102730_bib0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/jc.2013-2201","article-title":"Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis","volume":"99","author":"Daniels","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9856","key":"10.1016\/j.msard.2020.102730_bib0066","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(12)61768-1","article-title":"Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial","volume":"380","author":"Coles","year":"2012","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1016\/j.msard.2020.102730_bib0067","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2020.102730_bib0068","doi-asserted-by":"crossref","DOI":"10.1001\/archopht.1995.01100020014004","article-title":"The Optic Neuritis Treatment Trial: Three-Year Follow-up Results","author":"Beck","year":"1995","journal-title":"Archives of Ophthalmology"},{"issue":"24","key":"10.1016\/j.msard.2020.102730_bib0069","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group","volume":"329","author":"Beck","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/practneurol-2015-001254","article-title":"Mimics and chameleons of optic neuritis","volume":"16","author":"Weerasinghe","year":"2016","journal-title":"Pract. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2020.102730_bib0071","first-page":"819","article-title":"Corticosteroid-associated atypical central serous chorioretinopathy in a patient with multiple sclerosis","volume":"10","author":"Kaya","year":"2017","journal-title":"Int. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0072","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/bjophthalmol-2014-305737","article-title":"The prevalence of microcystic macular changes on optical coherence tomography of the macular region in optic nerve atrophy of non-neuritis origin: a prospective study","volume":"100","author":"Pott","year":"2016","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.msard.2020.102730_bib0073","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/practneurol-2012-000283","article-title":"Diffuse multiple sclerosis and chronic central serous chorioretinopathy: pitfall not to ignore","volume":"13","author":"Milazzo","year":"2013","journal-title":"Pract. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2020.102730_bib0074","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"10.1016\/j.msard.2020.102730_bib0075","doi-asserted-by":"crossref","DOI":"10.1310\/hpj4908-710","article-title":"Amantadine: Multiple sclerosis-related fatigue","author":"Generali","year":"2014","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.msard.2020.102730_bib0076","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.1977.00500150085020","article-title":"Vision Loss Associated With Amantadine Hydrochloride","author":"Pearlman","year":"1977","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.msard.2020.102730_bib0077","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.exer.2019.02.010","article-title":"Effects of amantadine on corneal endothelium","volume":"181","author":"Dudley","year":"2019","journal-title":"Exp. Eye Res."},{"issue":"9","key":"10.1016\/j.msard.2020.102730_bib0078","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.ophtha.2008.03.011","article-title":"Amantadine-associated corneal edema potentially irreversible even after cessation of the medication","volume":"115","author":"Jeng","year":"2008","journal-title":"Ophthalmology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482030804X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482030804X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:54:02Z","timestamp":1761900842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482030804X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":78,"alternative-id":["S221103482030804X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102730","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuro-ophthalmologic manifestations of multiple sclerosis other than acute optic neuritis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102730"}}